SCHEMBL13633538

SCHEMBL13633538

Cc1ccc(S(=O)(=O)Nc2cc(Br)cc(C(=O)O)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 2/20 0.54
▸ KDM4E B2RXH2 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ HSD11B1 P28845 1/20 0.45
▸ GAA P10253 2/20 0.45
▸ EGFR P00533 1/20 0.44
▸ PTGS1 P23219 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ CYTH2 Q99418 1/20 0.43
▸ ALKBH2 Q6NS38 1/20 0.43
▸ ALKBH5 Q6P6C2 1/20 0.43
▸ ALKBH3 Q96Q83 1/20 0.43
▸ FTO Q9C0B1 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ FFAR4 Q5NUL3 1/20 0.43
▸ CA12 O43570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13749459 0.84 KDM4E (0.49) METAP2KDM4EALDH1A1LMNAHSD11B1
SCHEMBL13633551 0.84 ALDH1A1 (0.53) KDM4EALDH1A1LMNAGAAPOLB
SCHEMBL13633458 0.79 KDM4E (0.49) METAP2KDM4EALDH1A1LMNAHSD11B1
SCHEMBL13789387 0.77 KDM4E (0.50) METAP2KDM4EALDH1A1LMNAHSD11B1
SCHEMBL13633501 0.73 KDM4E (0.58) METAP2KDM4EALDH1A1LMNAPOLB
SCHEMBL19083016 0.70 METAP2 (1.00) METAP2LMNA
SCHEMBL13638237 0.70 ALKBH2 (0.64) KDM4EALDH1A1LMNAGAAPTGS2
SCHEMBL14908004 0.69 KDM4E (0.68) KDM4EALDH1A1LMNAHSD11B1GAA
SCHEMBL3146296 0.69 KDM4E (0.58) KDM4EALDH1A1LMNAHSD11B1FFAR4
SCHEMBL3006653 0.69 HSD11B1 (0.67) KDM4EALDH1A1LMNAHSD11B1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 — — US disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 — — US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 — — US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191394-A1 Antibacterial agents MRPL21, RPN2, FBL METAP2 2179/4885KDM4E 4500/4885ALDH1A1 637/4885
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS DPYD, TYMP, ITPA METAP2 1293/4885KDM4E 4078/4885ALDH1A1 272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback